XGenomes Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $450K

  • Investors
  • 20

XGenomes General Information

Description

Developer of a health technology platform designed for deoxyribonucleic acid (DNA) sequencing and epigenetic analysis for improved health insights. The company offers an advanced method combining imaging and artificial intelligence to decode molecular signals, enabling clients to improve lifelong health monitoring, early disease detection, and personalised intervention tracking.

Contact Information

Website
www.xgenomes.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Decision/Risk Analysis
Other Industries
Other Pharmaceuticals and Biotechnology
Diagnostic Equipment
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States
+1 (617)

XGenomes Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XGenomes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Grant 30-Sep-2026 $450K Completed Generating Revenue
14. Later Stage VC 01-Apr-2026 Completed Generating Revenue
13. Grant 15-Sep-2025 Completed Startup
12. Grant 01-Jun-2026 Completed Generating Revenue
11. Grant 01-Jun-2025 Completed Generating Revenue
10. Grant 01-Jan-2025 Completed Generating Revenue
9. Later Stage VC 21-Feb-2024 Completed Generating Revenue
8. Seed Round 30-Mar-2022 Completed Generating Revenue
7. Seed Round 04-Sep-2019 $3.1M $3.25M Completed Generating Revenue
6. Accelerator/Incubator 01-Sep-2019 $150K Completed Generating Revenue
To view XGenomes’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

XGenomes Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a health technology platform designed for deoxyribonucleic acid (DNA) sequencing and epigenetic analysis fo
Decision/Risk Analysis
Cambridge, MA
7 As of 2026

San Diego, CA
 

Menlo Park, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

XGenomes Competitors (9)

One of XGenomes’s 9 competitors is Element Biosciences, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Element Biosciences Venture Capital-Backed San Diego, CA
BillionToOne Formerly VC-backed Menlo Park, CA
Illumina Formerly VC-backed San Diego, CA
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
Tempus AI Formerly VC-backed Chicago, IL
You’re viewing 5 of 9 competitors. Get the full list »

XGenomes Patents

  • 36

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 16

    Pending

  • Expiring in next 12 mo

XGenomes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4392781-A1 Random epigenomic sampling Pending 25-Aug-2021
EP-4392781-A4 Random epigenomic sampling Pending 25-Aug-2021
US-20240386997-A1 Random epigenomic sampling Pending 25-Aug-2021
WO-2023028270-A1 Random epigenomic sampling Inactive 25-Aug-2021
EP-4320268-A2 Systems, methods, and compositions for detecting epigenetic modifications of nucleic acids Pending 06-Apr-2021 C12Q1/6874
To view XGenomes’s complete patent history, request access »

XGenomes Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XGenomes Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Aeronautics and Space Administration Government
The National Human Genome Research Institute Government
National Institute of General Medical Sciences Government
Agilent Technologies Corporation
National Cancer Institute Government
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial

XGenomes FAQs

  • When was XGenomes founded?

    XGenomes was founded in 2016.

  • Where is XGenomes headquartered?

    XGenomes is headquartered in Cambridge, MA.

  • What is the size of XGenomes?

    XGenomes has 7 total employees.

  • What industry is XGenomes in?

    XGenomes’s primary industry is Decision/Risk Analysis.

  • Is XGenomes a private or public company?

    XGenomes is a Private company.

  • What is XGenomes’s current revenue?

    The current revenue for XGenomes is .

  • How much funding has XGenomes raised over time?

    XGenomes has raised $5.15M.

  • Who are XGenomes’s investors?

    National Aeronautics and Space Administration, The National Human Genome Research Institute, National Institute of General Medical Sciences, Agilent Technologies, and National Cancer Institute are 5 of 20 investors who have invested in XGenomes.

  • Who are XGenomes’s competitors?

    Element Biosciences, BillionToOne, Illumina, Oxford Nanopore Technologies, and Tempus AI are some of the 9 competitors of XGenomes.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process